Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Other2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT04010071Phase 2Unknown
Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors
Biliary Tract NeoplasmsHepatobiliary NeoplasmLiver Neoplasm
StudychairStart date: 2020-05-01

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Peking Union Medical College Hospital (PUMCH)

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04010071Phase 2StudyChair

Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors

Biliary Tract NeoplasmsHepatobiliary NeoplasmLiver Neoplasm
Unknown
NCT04896528Phase 2StudyChair

Efficacy and Safety of Avatrombopag in Cancer Patients With Thrombocytopenia

AvatrombopagThrombocytopenia
Unknown

All 2 trials loaded